RxDoctor Payments DataLook up a doctor →

Benjamin Seeman, DO

Interventional Pain Medicine · Richmond, VANPI 1750426987

Payments from drug & device makers

$28,424in general payments, 2019–2025

Across 366 payments — averaging $77.66 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$18K
  • Stryker$1K
  • Si-bone, Inc.$1K
  • Pacira Pharmaceuticals Incorporated$1K
  • Amgen$836
  • Stimwave Technologies Incorporated$450
  • plus $5K from 54 others

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Medtronic(2 entities)61$18,355
Stryker14$1,427
Si-bone, Inc.15$1,344
Pacira Pharmaceuticals Incorporated11$1,339
Amgen(2 entities)62$836
Stimwave Technologies Incorporated5$450
IBSA Pharma Inc.17$386
Nalu Medical, Inc.5$367
Scilex Pharmaceuticals Inc.21$302
MML US, Inc.4$286
Tactile Systems Technology Inc5$269
Biohaven Pharmaceuticals, Inc.11$249
Fidia Pharma USA Inc.12$230
Biohaven Pharmaceutical Holding Company Ltd.9$226
Averitas Pharma Inc.11$216
AbbVie(2 entities)9$165
Avanir Pharmaceuticals, Inc.3$164
Johnson & Johnson(2 entities)2$142
Assertio Therapeutics, Inc.9$131
Novartis11$121
Vertex6$118
Medline Industries LP1$101
Globus Medical3$100
Nevro Corp.5$92
Vertos Medical, Inc.3$83
Relievant Medsystems, Inc.3$74
Bioventus LLC3$55
Pfizer3$52
SPR Therapeutics, Inc2$44
GRT US Holding, Inc.3$39
Azurity Pharmaceuticals, Inc.2$37
Merz North America, Inc.2$37
Arbor Pharmaceuticals, Inc.2$36
Vertical Pharmaceuticals, LLC2$36
Acelrx Pharmaceuticals, Inc.2$30
Collegium Pharmaceutical, Inc.2$30
Cumberland Pharmaceuticals, Inc.1$30
Ipsen Biopharmaceuticals, Inc1$28
Trice Medical, Inc.1$27
Merz Pharmaceuticals, LLC1$26
Biodelivery Sciences International, Inc.2$24
Lundbeck LLC1$22
Davol Inc.1$22
Abbott1$21
Promius Pharma LLC1$21
Tonix Medicines, Inc.1$21
Curonix LLC1$20
USWM, LLC1$19
Upsher-smith Laboratories LLC1$18
Sanofi1$18
Sanofi-aventis U.S. LLC1$17
Biogen1$17
Novo Nordisk1$15
Lenoss Medical Inc1$14
Teva Pharmaceuticals USA, Inc.1$14
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC1$13
Forte Bio-pharma LLC1$13
Lilly USA, LLC1$12
Boston Scientific1$12
Currax Pharmaceuticals LLC1$11

How this compares

$28,424 in reported general payments places this provider in the 90th percentile of 52 interventional pain medicine providers in Virginia.

See all interventional pain medicine providers in Virginia →

Medicare billing

Part B allowed, 2024
$161,051
Medicare patients
166
Services billed
8,223

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other interventional pain medicine in Richmond

See the full list for Virginia →

Where these figures come from

Is this you, or does something look wrong? →